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P R O P E RT Y

With some important exceptions, empirical evidence
suggests patent protection reduces innovation.

Of Patents
and Property
B Y JAMES B ESSEN

AND

M ICHAEL J. M EURER

Boston University School of Law

T

here is property, and then there is property. Scholars hotly debate whether intellectual property is truly property and
which lessons learned about property
rights in land should be applied to property rights in inventions and other intellectual property.
A patent and property kerfuffle between the University of
Chicago’s Richard Epstein and California, Berkeley’s Peter
Menell played out in recent issues of Regulation and other venues. (See “The Property Rights Movement and Intellectual
Property” and “Intellectual Property and the Law of Land,”
Winter 2007; “A Final Response to Menell,” Spring 2008.)
Epstein and Menell debated the degree of kinship between
patent law and other forms of property law, focusing on the
proper role of injunctive relief in patent lawsuits. Recently, in
eBay v. MercExchange, the Supreme Court eliminated the presumption that an injunction is appropriate in all but exceptional cases of patent infringement. Epstein, responding to the
decision, acknowledged that inventions are an unruly sort of
property and that injunctions might not be appropriate for
some types of patent cases, but he nonetheless criticized eBay
and concluded “strong property protection via injunctions”
is necessary to limit uncertainty and assure adequate rewards
to inventors. Menell defended the Court for restoring the traditional discretion of trial court judges to fashion equitable
relief. He argued that the patent system needs “more flexibility at the remedy stage” to cope with problems plaguing the

U.S. patent system. Epstein prefers to deal with problems in
the patent system directly; he says, “Direct fixes for those
defects are surely preferable to mucking around with the core
protection of injunctive relief.”
While Epstein and Menell engage these issues on a theoretical plane, we think that at the heart of their disagreement
is an empirical question: Do patents, in fact, behave substantially like property rights in tangible assets? If they do, then
mucking around with injunctive relief might well increase
uncertainty; if not, then the issue is a bit more complicated.
This empirical question is the focus of our new book, Patent

James Bessen is lecturer in law at Boston University School of Law and director
of Research on Innovation.
Michael J. Meurer is the Michaels Faculty Research Scholar and professor of law
at Boston University School of Law.

This paper is adapted from Bessen and Meurer’s book Patent Failure: How
Judges, Lawyers, and Bureaucrats Put Innovators at Risk (Princeton University

Press, 2008).
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Failure, and we will recount part of our book’s discussion in this
article. Economists have adduced abundant evidence that strong,
tangible property regimes promote markets, investment, and economic growth. Thus, we ask, do patents likewise promote markets for technology, investment in research and development, and
economic growth? The tricky part of this sort of analysis is
establishing causation as well as correlation. It is quite evident
that wealthier and technologically advanced countries have
stronger and better-developed patent systems. That is, welldeveloped patent systems might cause economic growth in
those nations. Or it might be, instead, that successful technology companies or other groups, such as the patent bar, have lobbied for patent protection. In the latter case, economic success
promotes the expansion of the patent system, not the other
way around. Indeed, patent systems in advanced nations today
consist of highly sophisticated institutions supported with substantial funds. Those institutions were not simply legislated, but
they developed, along with a wide variety of other legal and
social institutions. Their evolution required both extensive experience and a large allocation of resources, and they would seem
as out of place in 19th century America as they would in many
of today’s less developed nations. Thus the correlation between
the sophistication of a nation’s technology and the sophistication of its patent system does not provide evidence of a causal
link by itself. A more advanced analysis is required.
Empirical research has advanced to the point that we can
do a more rigorous comparison of patents and other forms of
property. Our objective is not to obtain a conclusive finding on
whether patents are good policy instruments or not — whether,
for instance, they increase “net social welfare.” Instead, we simply aim to compare the evidence of economic payoff from general property rights to the evidence on the economic payoff
from patents. If the analogy to traditional property is close,

then we should see similar evidence of economic payoff.
As we shall see, the evidence paints a rather mixed picture.
In some industries, such as pharmaceuticals, patents provide
strong positive incentives to invest in innovation. But in many
other industries, perhaps most, patents fail to perform like
property and they may actually discourage innovation.
H I STO R I CA L EV I D E N C E

In what ways might we expect patent rights to perform similarly
to rights in tangible property? Property rights provide incentives
to invest, to trade, and to finance. Similar economic benefits are
ascribed to patents. Patents provide incentives to invest in
research and development and other innovative effort. Patents
also provide incentives to invest in the commercialization and
further development of an invention, and for investors to invest
in companies holding patents. In addition, patents provide
security to license and sell technology. These incentives are held
to promote innovation and economic growth.
Economic historian and Nobel Laureate Douglass North
has argued persuasively that the British Industrial Revolution
was facilitated by secure property rights. Many European
nations were hobbled with feudal customary rights that were
often disputed, undocumented, and hard to establish. In contrast, by the time of the Industrial Revolution, writes economic
historian Joel Mokyr, Britain’s government was “one of, by, and
for private property.” Britain had well-defined private property rights, less arbitrary courts and police, and institutions
that limited confiscatory taxation. That reduced transaction
costs and encouraged the growth of markets, allowing for
greater specialization, economies of scale, and more secure
returns on investment. Those benefits are seen as important
preconditions for the innovations and, ultimately, the economic growth that arose from the Industrial Revolution.
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North includes patents among Britain’s advantageous
property rights during the Industrial Revolution. Britain’s
patent law dates from 1624, while most other European countries did not have patent laws until the end of the 18th century. But more than a few economic historians are skeptical
about the significance of patents for the British Industrial Revolution, as Mokyr notes.
One reason for his skepticism is that relatively few inventors
of key technologies prior to the mid-19th century seemed to
benefit from patents. James Hargreaves and Samuel Crompton,
inventors of cotton spinning machines, did not obtain patents.
Crompton did not obtain a patent because Richard Arkwright
held a broad patent on spinning technology. (Crompton did
later receive compensation from Parliament.) Arkwright had
patents, but his key patent was challenged and invalidated; he
nevertheless made a fortune. Edmund Cartwright, inventor of

inventive step prior to the 20th century. One study found that
42 percent of patents were either partly or wholly anticipated by
earlier patents and many inventions were patented multiple
times. Also, prior to 1883, the British patent system was very costly, both in fees and in the indirect costs of bureaucratic red tape.
H. I. Dutton is perhaps the economic historian with the most
optimistic interpretation of the British experience. He cites evidence that hundreds of inventors did patent, many obtained
multiple patents, and that there was some trade in patents. This
suggests that some inventors obtained some benefit from
patents, but it does not mean that they received a net benefit
from patents — the costs of litigation and disputes can easily
offset the gains. Dutton and others recognize that litigation
costs were substantial. He floats the idea that despite those
major problems, patents may have encouraged innovation
because perhaps inventors accepted the “socially wholesome illu-

In Britain, relatively few inventors of
key technologies prior to the mid-19th century
seemed to benefit from patents.
the power loom, and Richard Roberts, inventor of a successful
automatic spinning machine, both obtained patents on their
inventions, but were unable to earn profits from them despite
the ultimately wide adoption of their machines. John Kay,
inventor of an improved weaving shuttle, and the Fourdrinier
brothers, inventors of a paper-making machine, were both
nearly ruined by the costs of patent litigation.
James Watt is a happy and prominent exception. Watt
obtained a patent on his improved steam engine design and,
thanks in part to Parliament’s extension of the patent term,
the firm of Boulton and Watt made a substantial return on
the investment needed to commercialize the invention. But we
should not overestimate the significance of Watt’s example.
His reputation appears to have outpaced the merit of his
inventions, which made only a limited contribution to economic growth. Most of the impact of the steam engine on economic growth appears to have come much later, after many
additional improvements had been made in steam engine
efficiency. This is significant because Nuvolari shows that
most of this later increase in efficiency can be attributed to
“collective invention,” where engineers actively shared inventions rather than patented them.
Economic historians have suggested several reasons why
patents may not have played a role similar to other property
rights in Britain. A major problem was that patent litigation was
costly and risky. Courts were not always sympathetic to patent
holders, patent law was complex, and patents could be invalidated. Litigation may have been more common than necessary
because Britain had a registration system instead of patent
examination. British patents were not examined for novelty or
20 R EG U L AT I O N W I N T E R 2 0 0 8 – 2 0 0 9

sion” that the patent system was more perfect than it really was.
But Christine MacLeod finds that about nine out of 10 patents
arose in industries that saw little innovation, and that patenting was at best loosely related to technological innovation. And
although there were some inventors who obtained 10 or more
patents and although there was some trade in patents, the
numbers were small, especially in comparison to those in the
United States, even though the United States lagged in economic development. Petra Moser, using information on inventions exhibited at the 1851 Crystal Palace World’s Fair, finds that
only 11 percent of British inventions were patented. So it seems
particularly hard to argue that British patents played a very significant role during the Industrial Revolution, even if some
inventors had irrational expectations of the patent system.
U N I T E D STAT ES
The experience in the United States was
quite different from that in Britain. The United States initiated patent examination in 1836 and patent fees were quite low.
When examination standards were relaxed during the 1850s,
patent applications soared, leading to what Zorina Khan calls
the “Democratization of Invention.” Individual mechanics
and farmers could and did obtain patents in large numbers,
and an active market for patents developed that lasted until the
end of the century. And although there were some well-known
cases where patents were “invented around,” such as Eli Whitney’s cotton gin and Francis Cabot Lowell’s power loom (which
he copied from British models), many of the famous inventors
in the United States did make profits from patented inventions.
So patents may have played a more positive role in the economic growth of the United States, although research has not
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yet established the extent of that contribution. On the other
hand, the ready availability of patents also had a dark side: it permitted small groups or individual firms to accumulate patent
“thickets” or to set up patent pools that may have substantially extended their market power and posed entry barriers or disincentives to other innovators. The first patent pool was formed
for sewing machines in 1856 after extensive litigation. Also in
the 1850s, the Draper Co. perfected the technique of amassing
a large number of patents to extend its monopoly, first with
patents on loom temples, then with spinning spindles beginning in the 1870s, and later with the Northrup automatic loom
in the 1890s. Draper controlled over 400 patents on spindles and
over 2,000 patents on the automatic loom. This arsenal and
Draper’s aggressive litigation posture allowed it to monopolize
key textile equipment for many decades.
Despite its faults, the U.S. patent system possibly had a
much more positive effect on innovation and economic
growth than the British system. But the differences only
underline the contingent nature of the benefits of a patent system. They depend very much on the details of the system and
the nature of the institutions that support it.
INTERNATIONALLY There were also important differences
across industries and technologies. This is evident in Moser’s
research on the effect of patents on innovation in different
countries during the 19th century. Moser measures national
innovation by looking at the number of important innovations (selected by panels of experts at the time) each nation displayed at world’s fairs in 1851 and 1876. She finds that nations
with patent systems were no more innovative than nations
without patent systems. Similarly, nations with longer patent
terms were no more innovative than nations with shorter
patent terms. However, patents did seem to make a difference
in national patterns of specialization. In countries without
patents, innovation was centered on industries that appeared
to have strong trade secrecy protection; in countries with
patents, this was not the case.
So, in contrast to general property rights, patents had a
much more uneven and limited effect on economic development during the 19th century. The role of patents seems to
have varied depending on the specific features of patent institutions, the technologies, and industries involved.

CROSS-COUNTRY STUDIES

In recent years, economists have developed a large literature
comparing the economic performance of different countries as
a means of identifying factors that influence economic growth.
The studies use panels of data that typically consist of dozens
of countries observed over several decades. They conduct multiple regression analyses to control for a wide variety of factors
that are thought to influence growth. Property rights institutions have featured prominently in this literature. Patent and
other intellectual property rights also appear in several studies;
the results for those measures have been quite different from
the results for more general measures of property rights.
Early studies used measures of political instability and
measures of civil rights as proxies for the quality of property

rights institutions. Philip Keefer and Stephan Knack developed indices that capture contract enforceability, risk of government expropriation, rule of law, constraints on the executive branch of government, and bureaucratic quality. They
incorporated those variables in a regression of each country’s
per-capita economic growth rate, including additional controls for education, labor force growth, and other factors.
Across a variety of specifications, they found that the quality
of property rights institutions is strongly and positively correlated with a nation’s economic growth rate.
However, Keefer and Knack did not control for “reverse
causality,” that is, for the possibility that economic growth may
have caused improvements in property rights institutions
instead of the other way around. As above, this might be the
case if, say, wealthier nations tended to allocate more resources
to improving property institutions because wealthier nations
have more property potentially at risk from bad institutions.
Robert Hall and Charles Jones build a similar model that does
control for reverse causality. Again, the property variables show
a strong relationship with economic growth.
The same cannot be said for patents or intellectual property rights. David Gould and William Gruben use a measure
of a country’s strength of patent protection in a regression
similar to that of Keefer and Knack. In their base model, the
patent index has a positive coefficient, but it is not statistically
significant. They try a wide variety of other specifications
and interactions, and in a few cases they obtain coefficients
that are statistically significant, but most results are only
weakly significant. Moreover, this study has some important
limitations that make any results difficult to interpret. In
particular, their regressions do not include measures of other
property rights — one might expect patent rights to be correlated with other property rights, which, as above, are known
to have a positive effect on economic growth — nor do they
control for reverse causality.
Walter Park and Juan Carlos Ginarte conducted a more
elaborate study that included measures of general property
rights, specifically an index of “market freedom.” They also
used a more sophisticated measure of a country’s patent rights
and a more sophisticated estimation technique. In their base
regression, they find that the market freedom variable has a
positive and statistically significant effect on economic
growth, but the intellectual property rights index has a negative coefficient that is not statistically different from zero.
However, although intellectual property rights do not appear
to have a direct positive effect on economic growth, they find
some limited evidence that intellectual property rights are correlated with a country’s research and development spending.
It might be the case that intellectual property rights encourage such spending, but the effect is too small to show up as a
major direct influence on economic growth. But even this
result is limited for two reasons. First, Ginarte and Park find
that it only holds among the wealthier countries in their sample. Second, they do not control for reverse causality — that
is, firms that spend a lot of research and development might,
after they become established, lobby for stronger patent laws.
In a separate paper, Ginarte and Park look at the factors that
R EG U L AT I O N W I N T E R 2 0 0 8 – 2 0 0 9
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determine a country’s intellectual property rights. They find, in
fact, that lagged research and development is positively correlated
with subsequent intellectual property rights strength. This suggests that there is, indeed, a significant reverse causality.
In summary, the qualitative difference between regression
results for general property rights and those for intellectual
property rights is striking. General property rights have a
strong and direct influence on economic growth that is robust
to a wide variety of specifications and to controls for reverse
causality. In contrast, intellectual property rights appear to
have at best only a weak and indirect relationship to economic growth, the relationship appears to apply only to certain groups of countries or certain specifications, and the
direction of causality is unclear.
Intellectual property rights are not just like other property rights and simple casual observations about the correlation
between U.S. or Western technology and patent systems can

and entered a period of positive and, in some cases, rapid economic growth. The outcome apparently depended on the particular set of reforms that each country adopted. Svejnar distinguishes two levels of reforms. Almost all of the countries
initiated “Type I” reforms involving macroeconomic stabilization policies, removal of price controls and subsidies, and dismantling of the institutions of the communist system. Some
countries — notably Poland, Hungary, Slovakia, and Slovenia
— also pursued “Type II” reforms that permitted the development of government policies and institutions to support a
robust market economy. Type II reforms included privatization
of large enterprises and establishment of effective market-oriented legal systems, commercial banking, regulatory infrastructure, and labor market regulation. Type II reforms were
critical in providing a reliable tax base for government agencies and for limiting corruption and rent-seeking behavior.
And they appear to have made the crucial difference in eco-

Intellectual property rights appear to
have at best only a weak and indirect relationship
to economic growth.
be misleading. On the other hand, this does not mean that
patents have no measurable effects, just that it appears that
their effects may be more tentative, contingent upon the
details of the patent system or dependent on the particular
technology, industry, or state of economic development.
N AT U R A L E C O N O M I C E X P E R I M E N T S

One way that researchers have sought to untangle the direction of causality is to look at “natural economic experiments”
— compare economic activity before and after a discrete change
in the law. Even though economic policy may have changed
in response to “endogenous” factors (such as successful firms
lobbying for stronger property rights), when the change occurs
as a sharp break, the effect of that change should be observable immediately after it goes into effect. There are studies of
natural economic experiments both for changes in property
rights generally and for patent rights specifically.
Perhaps the biggest economic experiment in recent years is
the transition of Eastern European economies from centralized
planning to market-based economies beginning with the collapse of the Soviet system in the late 1980s. Jan Svejnar studied the economic performance of the countries that made
that transition. Prior to the fall of the Iron Curtain, per-capita gnp growth had declined steadily in Soviet Bloc countries
for decades, to a level of 0.8 percent growth per annum during
the 1980s. Economists had high expectations that moving to
a market system would generate an immediate, rapid increase
in economic growth. But that did not happen. Per-capita gnp
fell rapidly in all the countries, but some eventually recovered
22
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nomic performance — the countries that initiated Type II
reforms now have strong economic growth in contrast to those
countries that adopted more limited institutional change.
This analysis suggests that when it comes to the economic effects of property, the devil is in the details. It is not
enough to eliminate centralized control and provide legal
rights to property. Effective economic performance depends
on well-developed public and private institutions to support
the property system, and those institutions are often more difficult to develop.
The evidence from changes in patent law suggests that the
devil may be even more deeply hidden in the details of patent
institutions. Mariko Sakakibara and Lee Branstetter looked at
the effect of a 1988 law that increased patent scope in Japan.
They found no evidence of an increase in either research and
development spending or innovative output that could be
plausibly attributed to the patent reform. James Bessen and
Robert Hunt looked at the effect of changes in the U.S. treatment of inventions that involve software, and they found that
the number of software patents grew dramatically. However,
firms in the software industry acquired relatively few patents;
instead, most were obtained by firms in electronics and computer industries known for stockpiling large arsenals of patents
to use as bargaining chips. Moreover, the firms that acquired
relatively more software patents tended to actually reduce their
level of research and development spending relative to sales.
Several studies have looked at the effect of extending patent
protection to pharmaceutical products and processes. Many
countries historically have limited patent coverage of phar-
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maceuticals, but they extended coverage in recent decades
under pressure from trade negotiators. F. M. Scherer and S.
Weisburst studied the effect of strengthened drug patents
introduced in Italy in 1978 and found no evidence that drug
research and development accelerated within the well-established Italian drug manufacturing industry after the law
change. Jean Lanjouw and Iain Cockburn studied the effect of
the “trips” treaty that went into effect in 1995 and required
about 40 less-developed signatory countries to implement
pharmaceutical patent protection by 2005. Among other
items, they looked at the research and development allocated
to products specifically directed to less-developed country
markets. They did find some increase in spending during the
mid- and late 1980s, perhaps in anticipation of the changes.
However, the trends appear to have leveled off or reversed
during the 1990s when the trips changes went into effect.
All of those studies are subject to the caveat that other,
simultaneous changes might have caused a reduction in innovation or in research and development, potentially confounding the results. However, the similarity of results across the various studies suggests that confounding factors are not
responsible for most of what has been observed. One study uses
the power of numbers to limit the explanatory role of possible confounding effects. Josh Lerner looks at 177 changes in
patent law that “strengthened” patents in a panel of 60 countries over 150 years. In such a large sample, the role of confounding factors should be limited — positive confounding
events will tend to be offset by negative confounding events in
estimates of the average response. In his accounting of events
that strengthened patents, Lerner includes changes in substantive law that improved the scope or extent of patent rights
and he also includes reductions in patent fees. Although the
latter does not strictly imply an increase in patent rights, invenFigure 1

Patents and Domestic Innovation
Patent applications around the time of
patent law strengthening
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“150 Years of Patent Protection,” by Josh Lerner (American Economic Review, Vol. 92, No. 2)

tors have been found to increase their rates of patenting in
response to cheaper patents. Lerner is not able to measure
directly the effect of the changes on innovation. Instead, he
measures their effect on patenting within the country making
the change and also the effect on patenting by domestic inventors at Great Britain’s Patent Office. As indicated in Figure 1,
he finds that foreign inventors increased their patenting in
countries that strengthened their patent laws. However, domestic inventors actually patented at a lower rate after the change,
both within their country and at the British Patent Office.
Exploring alternative specifications, Lerner finds that the
decline applies more to poor nations and nations with initially lower levels of patent protection. Nevertheless, the overall
results seem consistent with the studies of changes in pharmaceutical patent coverage: it may benefit foreign inventors
who trade in patented goods, but it is not clear from the studies that stronger patent laws improve domestic innovation.
FREE-RIDING

It is helpful to ask whether patents do, in fact, play the role
prescribed for them in economic theory. The standard argument is that without patents, inventions will be quickly copied
by imitators. Competition from the “free-riders” will drive
down prices, making it impossible for the inventor to earn sufficient profits to recoup his investment in developing the
invention. Without the promise of secure profits, inventors
will not invest in the first place, so the argument goes.
This is a plausible and oft-told tale, but what is the actual
evidence to support it? Do patents prevent the market entry
of free-riders who would otherwise destroy or reduce incentives to innovate? Empirical research suggests that the answer
is “sometimes” and “to some extent.” This may help explain
the nature of the findings described above.
The canonical example of the free-riding problem is traditional drug development (biotech is different in some important
respects). Joseph Dimasi, Henry Grabowski, and Ronald Hansen
estimate that the average out-of-pocket cost for a drug company to develop a new drug, including the costs of research projects that were abandoned, is $402 million (in 2000 dollars).
About 70 percent of that cost is incurred during the clinical trials necessary to obtain government approval. Generic drug manufacturers are not required to repeat the same clinical trials, so
their research and development costs are far less than those of
the original manufacturer. This means that when patents expire,
generic manufacturers can enter the market and compete at
lower prices. In a separate study, Grabowski and John Vernon
find that drug prices drop to 37 percent of their original level
two years after the entry of generic manufacturers. The higher
prices that pharmaceutical firms charge while they are still on
patent allow them to earn above-normal profits — “rents” — that
more than recoup their development investments.
But the pharmaceutical industry may be atypical. Certainly, few other industries have such a high regulatory burden on initial innovation. Typically, imitators are not at such
a large cost advantage relative to initial innovators. Edwin
Mansfield, Mark Schwartz, and Samuel Wagner, using survey
data, find that imitation cost and imitation time are about
R EG U L AT I O N W I N T E R 2 0 0 8 – 2 0 0 9
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two-thirds of the original development cost and time on average. This is still an advantage for imitators, but not such a large
advantage; imitators also face significant entry costs.
Also, perhaps the nature of pharmaceutical patents —
patents on small, well-defined molecules — may enhance the
effectiveness of patenting in this industry. These patents have
clear boundaries that promote efficient enforcement of the
patent rights. Survey respondents told Mansfield et al. that
patents increased imitation costs only 7 percent for electronics and machinery inventions at the median; the figure was 30
percent for pharmaceutical inventions.
More generally, imitation costs are high aside from patents
because firms have means other than patents for protecting
their innovations. Innovators may earn above-normal profits
because they have lead-time advantages, or because they come
down a learning curve first; they may earn profits from complementary products and services, or they may rely on trade
secrecy. Surveys find that in most industries (pharmaceuticals
are the exception), research and development managers report
Figure 2

Patents, Profits, and Costs
A. Aggregate profits from patents and aggregate
litigation costs for public U.S. chemical and
pharmaceutical firms
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B. Aggregate profits from patents and aggregate litigation costs for public U.S. firms in other industries
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Patent Failure, by James Bessen and Micheal J. Meurer (Princeton University Press, 2008)
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that these other means of appropriation are more effective
than patents in obtaining returns on their investments. For
this reason, it is not surprising that survey research also finds
that most inventions are not patented. On average, large European firms applied for patents on only 36 percent of product
innovations and 25 percent of process innovations. Again,
pharmaceutical firms are outliers — they applied for patents
on 79 percent of pharmaceutical products.
This evidence does not mean that patents have no value.
Rather, the effectiveness of patents varies by industry and technology, and for many industries and technologies their effectiveness is limited. This assessment is supported by the estimates
of the private value of patents discussed in the next section.
E S T I M AT E S O F T H E N E T B E N E F I T

It is possible to make more direct estimates of the incentives
that patents provide to their owners. The gross private benefits of patents can be inferred from the value owners place on
their patents. And some of the major costs that patents impose
on innovators can be inferred from data on patent litigation.
Economists have used a variety of techniques to estimate the
private value of patents to their owners. Some estimates are
based on the observed behavior of patent owners, such as their
willingness to pay fees to keep patents in force or their willingness to patent in multiple countries. Other estimates are
based on the contribution that patents make to the stock market value of public firms. The good news is that these different methods produce estimates that roughly correspond. Not
surprisingly, patent values vary tremendously, depending on
the industry. The average value of patents held by large pharmaceutical firms is easily an order of magnitude larger than the
average value of patents held by firms in other industries.
Because the value of a patent can be thought of as the
expected present value of the profit stream from the patent,
the gross profits from a patent can be estimated by multiplying patent value by a rate of return, say, 15 percent. The profits represent the stream of rewards that provide an incentive
to invest in innovation.
However, patents may also impose disincentives on innovators. Litigation costs represent an important disincentive to
innovation. A firm looking to invest in innovation will consider the risk that the innovation will inadvertently expose it
to a patent-infringement lawsuit. Since infringement lawsuits
are usually filed against firms exploiting new technologies,
development of a new technology exposes the innovator to risk
of inadvertent infringement if patent boundaries are hidden,
unclear, or unpredictable. That risk weighs against the profits that can be made from innovation. Of course, firms are
both patent holders and potential defendants, so a comparison of profit flows and litigation costs for a group of firms
should reveal the sign of net incentives. Several studies have
estimated the expected cost of litigation using stock market
event studies around the date of patent lawsuit filings.
Figure 2 shows a comparison of estimates of the profits and
litigation risks from owning patents. The results in Figure 2A
show that chemical and pharmaceutical firms earn far more
from their patents than they lose to litigation. But for other
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firms, Figure 2B tells a simple but dramatic story: During the
1980s, these firms might have, at best, broken even from
patents, but in the mid-1990s, litigation costs exploded. By
almost any interpretation, the patent system could not be
providing overall positive incentives for those United States
public firms by the end of the 1990s. The risk of patent litigation that firms faced in their capacity as technology
adopters simply outstripped the profits that they made by
virtue of owning patents. A firm looking to invest in an innovative technology during the late 1990s, taking this risk into
account, would expect the net impact of patents to reduce the
profits from innovation rather than to increase them.
Note that patents do provide profits for their owners, so it
makes sense for firms to get them. But taking the effect of other
firms’ patents into account, including the risk of litigation, the
average public firm outside the chemical and pharmaceutical
industries would be better off if patents did not exist.
CO N C LUS I O N

The historical evidence, the cross-country evidence, the evidence from economic experiments, and estimates of the net
benefits of patents all point to a marked difference between the
economic importance of general property rights and the economic importance of patents or intellectual property rights
more generally. With the cross-country studies in particular, the
quality of general property rights institutions has a substantial direct effect on economic growth. Using the same methodology and in the same studies, intellectual property rights have
at best only a weak and indirect effect on economic growth.
The research also suggests a reason why patents differ from
general property rights in motivating economic growth overall: the positive effects of patents appear to be highly contingent. Differences in technology and industry seem to matter
a lot for 20th century research and development managers and

also for the innovative performance of 19th century world’s
fair exhibitors. Some results from the cross-country studies
suggest that less developed countries have a harder time realizing benefits from patents, or that countries that participate
actively in international trade may benefit more.
Some of these differences arise because of differences in the
relative costs and effectiveness of alternatives to patents.
Patents may contribute more to economic growth in the pharmaceutical industry than they contribute in electronics industries because the latter can more effectively earn returns on
innovation through lead time advantage, sales of complementary products and services, etc. Other differences may
arise because of subtle differences in patent institutions. During the 19th century, the U.S. patent institutions performed
differently (and perhaps better) than their British counterparts. Patents are likely to work better in the pharmaceutical
industry because patents on chemical entities have much
sharper boundaries than, say, patents on software.
Of course, the economic effectiveness of all forms of property depends on details of the supporting institutions — this
is evident from the disparate growth paths of Soviet Bloc
economies. But the economic effectiveness of patents may be
much more sensitive to the details of the relevant institutions than are general property rights. Perhaps this is because
patent law may be much more specialized, complex, and
sophisticated than, say, real property law and, so, effective
institutions may be more difficult to develop and maintain.
In any case, the empirical economic evidence strongly
rejects simplistic arguments that patents universally spur
innovation and economic growth. The direct comparison of
estimated net incentives suggests that for public firms in
most industries today, patents may actually discourage investment in innovation, and routine injunctive relief may conR
tribute to this problem.
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